Krsnaa Diagnostics Limited (NSE:KRSNAA)
India
· Delayed Price · Currency is INR 785.00
-5.55 (-0.70%)
Apr 2, 2025, 3:29 PM IST
Krsnaa Diagnostics Revenue
Krsnaa Diagnostics had revenue of 1.75B INR in the quarter ending December 31, 2024, with 10.23% growth. This brings the company's revenue in the last twelve months to 6.97B, up 18.89% year-over-year. In the fiscal year ending March 31, 2024, Krsnaa Diagnostics had annual revenue of 6.20B with 27.20% growth.
Revenue (ttm)
6.97B
Revenue Growth
+18.89%
P/S Ratio
3.67
Revenue / Employee
1.88M
Employees
3,700
Market Cap
25.53B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
Krsnaa Diagnostics News
- 4 months ago - Lab stops blood collection at 400 BMC hosps over pending dues - The Times of India
- 5 months ago - Krsnaa Diagnostics shares surge nearly 6% as Q2 net sales reach ₹186.34 crore - Business Upturn
- 6 months ago - Stock in Focus: Krsnaa Diagnostics secures two major agreements in Ranchi - Business Upturn
- 6 months ago - Krsnaa Diagnostics to acquire 24% stake in start-up Apulki Healthcare - The Times of India
- 6 months ago - Krsnaa Diagnostics secures radiology services contract at Sadar Hospital, Ranchi - Business Upturn
- 6 months ago - Krsnaa Diagnostics acquires stake in India’s first PPP cancer and cardiac care hospitals - Business Upturn
- 6 months ago - Krsnaa Diagnostics share price surges over 3% after company agrees to acquire 23.53% stake in Apulki Healthcare - Business Upturn